Thrombolytic Science jobs and careers

United States

About Thrombolytic Science

TSI is a privately-held vascular medicine and biotechnology company currently developing a new-generation clot-dissolving therapy with the first novel mechanism of action in 20 years for stroke and other thrombotic diseases. TSI’s technology is based upon pioneering earlier work on pro-urokinase (proUK) by its cofounders. The primary component of TSI’s thrombolytic therapy is a rationally designed mutant of proUK.

Employees: 1 to 10
Headquarters: United States

Leadership

The top of Thrombolytic Science's org chart, with how many people report into each leader.

Alexis C. Wallace

President & Chief Executive Officer, co-founder & board member

Jobs at Thrombolytic Science

No open positions right now. Explore more companies on TheJobsMap.